February 19, 2026 — Leads & Copy — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that management will participate in fireside chats at several upcoming investor conferences.
The conferences include:
Oppenheimer 36th Annual Healthcare Life Sciences Virtual Conference on Thursday, February 26, 2026.
TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026.
Leerink Global Healthcare Conference on Monday, March 9, 2026.
Barclays 28th Annual Global Healthcare Conference on Wednesday, March 11, 2026.
Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026.
Live webcasts of the presentations will be available in the Investors & Media section of the Ionis website.
Replays will be archived on the Ionis website within 48 hours for a limited time.
Ionis Pharmaceuticals, Inc. has been inventing medicines for three decades, aimed at improving the lives of individuals with serious diseases. The company has marketed medicines and a pipeline in neurology, cardiometabolic disease, and other areas with high patient needs. Ionis is focused on RNA-targeted medicines and is advancing new approaches in gene editing.
Source: Ionis Pharmaceuticals, Inc.
